These results strongly suggest that, in ER + breast cancer patients, high Rab31 antigen levels in tumor tissue are associated with a high proliferative status, and Rab31 is an independent biomarker for poor prognosis (Kotzsch et al. 2017). This evidence concerns the gene RAB31 and breast carcinoma.